Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Adjuvant Oy
OY
Dissolved
Y-tunnus 2479909-9
Papinkatu 10D-1030, 80110
Joensuu
Medical specialists activities
·
NACE 8622
Est. 2012 · 14 years old
— employees
Share
Finland
/
Companies
/
Medical specialists activities
/
Adjuvant Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
0M
2026
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
0M
0%
2026
Income statement
EUR thousands
Item
2022
2023
2024
2025
2026
Revenue
0
145
0
0
0
Staff expenses
−0
0
−136
−0
−0
EBITDA
−3
129
319
−3
−6
Depreciation & amort.
—
−0
−0
−0
−0
EBIT
−3
129
319
−3
−6
Net financials
479
2 432
1 216
−3
56
Profit before tax
476
2 561
1 535
−6
50
Tax
−0
23
92
4
10
Net profit
476
2 538
1 443
−10
40
Balance sheet
EUR thousands
Item
2022
2023
2024
2025
2026
Total assets
428
2 898
4 282
3 824
3 621
Equity
428
2 872
4 165
3 824
3 621
Long-term debt
—
0
0
0
0
Short-term debt
0
26
117
0
0
Total debt
0
26
117
0
0
Financial ratios
5-year trend
EBITDA-margin
-618300.0%
This company
15.8%
Market median
-3913391% vs market
2022
2026
Soliditetsgrad
100.0%
This company
38.2%
Market median
+162% vs market
2022
2026
Egenkapitalforrentning
1.1%
This company
18.4%
Market median
-94% vs market
2022
2026
Nettoresultatgrad
3999100.0%
This company
8.1%
Market median
+49371505% vs market
2022
2026
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2022
2026
Gæld/egenkapital
0.00×
This company
0.62×
Market median
+100% vs market
2022
2026
Annual reports & filings
Annual report 2026
Filed via PRH / YTJ · Period 2025-04-01 – 2026-03-31
View
PDF
Annual report 2025
Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
View
PDF
More on Adjuvant Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network